FrancophonIA/ELRC3.0 huggingface dataset:
English: Senshio must also not be used in women who have breast cancer or another cancer that is sex-hormone dependent such as endometrial cancer (cancer of the womb).
Estonian: Samuti ei tohi Senshiot kasutada naised, kellel on rinnavähk või muu suguhormoonidest sõltuv vähk, nt endomeetriumivähk (emaka limaskesta vähk).
English: Senshio is a medicine used to treat moderate to severe symptoms of vulvovaginal atrophy (dryness, irritation and soreness around the genital area, and painful sexual intercourse) in women who have been through the menopause.
Estonian: Senshio on ravim, mida kasutatakse vulvovaginaalse atroofia mõõdukate kuni raskete sümptomite (kuivus, ärritus ja valu suguelundite piirkonnas ning valulik suguühe) raviks menopausijärgses eas naistel.
English: How does Senshio work?
Estonian: Kuidas Senshio toimib?
English: Regarding pain during sexual activity, 58% of women using Senshio reported relief in the first study (compared with 42% receiving placebo) and 63% reported relief during the second study (compared with 48% receiving placebo).
Estonian: Esimeses uuringus teatas suguühte valulikkuse leevenemisest 58% Senshiot kasutanud naistest (42% platseeborühmas) ja teises uuringus 63% (48% platseeborühmas).
English: Oestrogen hormones help to maintain the health of tissue in and around the vagina.
Estonian: Östrogeenhormoonid aitavad hoida tupesisemuse ja -ümbruse koed tervena.
English: Senshio improved symptoms of vulvovaginal atrophy in postmenopausal women.
Estonian: Senshio parandas vulvovaginaalse atroofia sümptomeid menopausijärgses eas naistel.
English: The Agency noted that the degree of improvement with Senshio was comparable to that with oestrogen treatments that are applied to the vagina.
Estonian: Amet märkis, et Senshio leevendava toime ulatus on võrreldav vaginaalse östrogeenraviga.
English: For the full list of side effects and restrictionsof Senshio, see the package leaflet.
Estonian: Kõrvalnähtude ja piirangute täielik loetelu on pakendi infolehel.
English: In the second study, 62% of women using Senshio reported relief from vaginal dryness after 12 weeks (compared with 53% in the placebo group).
Estonian: Teises uuringus teatas 12-nädalase ravi järel tupekuivuse leevenemisest 62% Senshiot kasutanud naistest (53% platseeborühmas).
English: How is Senshio used?
Estonian: Kuidas Senshiot kasutatakse?
English: Some women must not use Senshio, including those who have or have had problems with blood clots in veins such as deep-vein thrombosis (DVT), pulmonary embolism (a blood clot in the lungs) and retinal-vein thrombosis (a blood clot at the back of the eye).
Estonian: Senshiot ei tohi kasutada osa naisi, sealhulgas need, kellel on või on olnud veenitrombid, näiteks süvaveenitromboos, kopsuemboolia (kopsutromb) ja võrkkestaveeni tromboos (silmapõhjatromb).
English: An overview of Senshio and why it is authorised in the EU
Estonian: Ülevaade ravimist Senshio ja ELis müügiloa väljastamise põhjendus
English: What benefits of Senshio have been shown in studies?
Estonian: Milles seisneb uuringute põhjal Senshio kasulikkus?
English: The main measure of effectiveness was related to the change in symptoms such as pain associated with sexual activity and vaginal dryness, using a validated questionnaire.
Estonian: Efektiivsuse põhinäitaja, mida hinnati valideeritud küsimustikuga, oli selliste sümptomite muutus nagu suguühte valulikkus ja tupekuivus.
English: In the first study, 66% of women using Senshio reported relief from vaginal dryness (mild or no symptoms) after 12 weeks' treatment compared with 49% in the placebo group.
Estonian: Esimeses uuringus teatas 12-nädalase ravi järel tupekuivuse leevenemisest (kerged sümptomid või sümptomid puudusid) 66% Senshiot kasutanud naistest (49% platseeborühmas).
English: This can cause irritation and soreness and make sexual intercourse painful.The active substance in Senshio, ospemifene, is a selective oestrogen receptor modulator (SERM).
Estonian: Senshio toimeaine ospemifeen on selektiivne östrogeeniretseptori modulaator (SERM).
English: This summary was last updated in December 2017.
Estonian: Kokkuvõtte viimane uuendus: detsember 2017.
English: This will help protect the pigs against porcine circovirus infections.
Estonian: See aitab kaitsta sigu sigade tsirkoviiruse nakkuste vastu.
English: In the future, if the animals come into contact with the virus the immune system will be able to respond quickly to destroy the virus.
Estonian: Kui loomad puutuvad hiljem viirusega uuesti kokku, suudab nende immuunsüsteem viiruse hävitamiseks kiiresti reageerida.
English: The purpose of these studies was to establish how long it took pigs to be fully protected and how long the protection against PCV2 lasted.
Estonian: Nende uuringute eesmärk oli vaadelda, kui kiiresti tekib sigadel PCV2 vastu täielik kaitse ning kui kaua see püsib.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Suvaxyn Circo's benefits are greater than its risks and recommended that it be approved for use in the EU.
Estonian: Veterinaarravimite komitee järeldas, et vaktsiini Suvaxyn Circo kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas vaktsiini kasutamise Euroopa Liidus heaks kiita.
English: Suvaxyn Circo+MH RTU is already approved in the EU.
Estonian: Suvaxyn Circo+MH RTU on Euroopa Liidus juba heaks kiidetud.
English: The studies showed that the vaccine had its full effect against PCV2 by three weeks after vaccination.
Estonian: Uuringutes selgus, et vaktsiini täielik toime PCV2 vastu tekkis kolm nädalat pärast vaktsineerimist.
English: The full EPAR for Suvaxyn Circo can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Estonian: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: The most common side effects with Suvaxyn Circo (which may affect more than 1 in 10 animals) are a short-lived increase in body temperature during the first 24 hours after vaccination and swelling (generally no wider than 2 cm) at the injection site which may last for up to 2 days.
Estonian: Vaktsiini Suvaxyn Circo kõige sagedamad kõrvaltoimed (võivad esineda enam kui 1 loomal 10st) on mööduv kehatemperatuuri tõus esimese 24 tunni jooksul pärast vaktsineerimist ja süstekoha turse (läbimõõduga kuni 2 cm), mis võib püsida kuni 2 päeva.
English: What is Suvaxyn Circo and what is it used for?
Estonian: Mis on Suvaxyn Circo ja milleks seda kasutatakse?
English: Protection lasted 23 weeks after vaccination for PCV2.
Estonian: Kaitse kestis 23 nädalat pärast PCV2 vastu vaktsineerimist.
English: Infections can produce clinical signs such as weight loss or failure to grow, enlarged lymph nodes, difficulty breathing, pale skin and jaundice (yellowing of the skin).
Estonian: Nakkustel võivad olla järgmised kliinilised nähud: kaalulangus või kasvupeetus, lümfisõlmede suurenemine, hingamisraskused, naha kahvatus ja kollasus.
English: Suvaxyn Circo is a veterinary vaccine used to protect pigs over the age of 3 weeks against porcine circovirus type 2 (PCV2).
Estonian: Suvaxyn Circo on veterinaarvaktsiin, mida kasutatakse vähemalt 3-nädalaste sigade kaitsmiseks sigade tsirkoviiruse tüüp 2 (PCV2) eest.
English: Suvaxyn Circo also contains adjuvants (ingredients that strengthen the immune response) called squalane, poloxamer 401 and polysorbate 80.
Estonian: Samuti sisaldab Suvaxyn Circo immuunvastuse tugevdamiseks adjuvante (skvaleen, poloksameer 401 ja polüsorbaat 80).
English: The European Commission granted a marketing authorisation valid throughout the EU for Suvaxyn Circo on 7 February 2018.
Estonian: Euroopa Komisjon andis vaktsiinile Suvaxyn Circo müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 07/02/2018.
English: The vaccine contains small amounts of a protein from PCV2 that have been killed (inactivated) so that they do not cause disease.
Estonian: Vaktsiin sisaldab väikestes kogustes PCV2-st saadud valku, mis on haiguse tekke takistamiseks hävitatud (inaktiveeritud).
English: Other information about Suvaxyn Circo
Estonian: Muu teave vaktsiini Suvaxyn Circo kohta
English: The withdrawal period for meat from pigs treated with Suvaxyn Circo is ‘zero' days, which means there is no mandatory waiting time.
Estonian: Vaktsiiniga Suvaxyn Circo vaktsineeritud sigade liha keeluaeg on 0 päeva, mis tähendab, et keeluaega ei ole.
English: The studies on the effectiveness of Suvaxyn Circo were carried out with a similar vaccine, Suvaxyn Circo+MH RTU, which contains PCV2 and the bacteria Mycoplasma hyopneumoniae.
Estonian: Vaktsiini Suvaxyn Circo efektiivsuse tõendamiseks tehti uuringud sarnase vaktsiiniga - Suvaxyn Circo+MH RTU, mis sisaldab PCV2 ja bakterit Mycoplasma hyopneumoniae.
English: Suvaxyn Circo porcine circovirus vaccine (inactivated)
Estonian: Suvaxyn Circo sigade tsirkoviiruse vaktsiin (inaktiveeritud)
English: For practical information about using Suvaxyn Circo, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Estonian: Kui loomaomanikud või -pidajad vajavad vaktsiini Suvaxyn Circo kasutamise praktilisi nõuandeid, peavad nad lugema pakendi infolehte või pöörduma oma veterinaararsti või apteekri poole.
English: This is a summary of the European public assessment report (EPAR) for Suvaxyn Circo.
Estonian: See on vaktsiini Suvaxyn Circo Euroopa avaliku hindamisaruande kokkuvõte.
English: Why is Suvaxyn Circo approved?
Estonian: Miks Suvaxyn Circo heaks kiideti?
English: It is not intended to provide practical advice on how to use Suvaxyn Circo.
Estonian: Hindamisaruandes ei anta vaktsiini Suvaxyn Circo kasutamise praktilisi nõuandeid.
English: The field studies showed that Suvaxyn Circo reduced the PCV2 viraemia (presence of virus in the blood) compared to pigs given dummy vaccination.
Estonian: Väliuuringutes tõendati, et Suvaxyn Circo+MH RTU vähendas sigadel PCV2 vireemiat (viiruse olemasolu veres) võrreldes sigadega, kellele manustati näivat vaktsiini.
English: The effectiveness of Suvaxyn Circo+MH RTU against PCV2 infection was also studied in three field studies.
Estonian: Vaktsiini Suvaxyn Circo+MH RTU efektiivsust PCV2 nakkuse vastu uuriti ka kolmes väliuuringus.
English: The effectiveness of Suvaxyn Circo+MH RTU was first studied in several laboratory studies in pigs.
Estonian: Vaktsiini Suvaxyn Circo+MH RTU efektiivsust uuriti kõigepealt mitmes sigadel tehtud laboriuuringus.
English: When Suvaxyn Circo is given to pigs the animals' immune system recognises the viral protein as ‘foreign' and makes antibodies against it.
Estonian: Kui sigadele manustatakse vaktsiini Suvaxyn Circo, peab looma immuunsüsteem viiruse valku võõraks ning tekitab selle vastu antikehi.
English: Suvaxyn Circo is a vaccine.
Estonian: Suvaxyn Circo on vaktsiin.
English: For the full list of restrictions and side effects with Suvaxyn Circo, see the package leaflet.
Estonian: Vaktsiini Suvaxyn Circo kohta teatatud piirangute ja kõrvaltoimete täielik loetelu on pakendi infolehel.
English: Suvaxyn Circo contains an inactivated (killed) active substance derived from porcine circovirus type 2.
Estonian: Suvaxyn Circo sisaldab inaktiveeritud (hävitatud) toimeainet, mis on saadud PCV2-st.
English: What are the risks associated with Suvaxyn Circo?
Estonian: Mis riskid vaktsiiniga Suvaxyn Circo kaasnevad?
English: How does Suvaxyn Circo work?
Estonian: Kuidas Suvaxyn Circo toimib?
English: Suvaxyn Circo, which is available as a liquid for injection, is given to pigs from three weeks of age as a single injection into the muscle in the neck behind the ear.
Estonian: Vaktsiini manustatakse vähemalt 3 nädala vanustele sigadele ühe süstina kaelalihasesse kõrva taha.
English: Suvaxyn Circo is only available on prescription.
Estonian: Suvaxyn Circo on retseptivaktsiin.
English: What benefits of Suvaxyn Circo have been shown in studies?
Estonian: Milles seisneb uuringute põhjal vaktsiini Suvaxyn Circo kasulikkus?
English: How is Suvaxyn Circo used?
Estonian: Kuidas vaktsiini Suvaxyn Circo kasutatakse?
English: 100 mg/ml
Estonian: Matever 100 mg/ml
English: This will help you to remember to take it.
Estonian: See aitab teil selle võtmist meeles pidada.
English: Try to take the tablet at the same time each day.
Estonian: Püüdke tabletti võtta iga päev samal ajal.
English: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, UK
Estonian: Austria, Belgia, Bulgaaria, Küpros, Tšehhi Vabariik, Taani, Eesti, Soome, Prantusmaa, Saksamaa, Kreeka, Ungari, Island, Iirimaa, Läti, Leedu, Luxembourg, Malta, Holland, Norra, Poola, Portugal, Rumeenia, Slovakkia, Sloveenia, Hispaania, Rootsi, Ühendkuningriik
English: It is important that you are aware of what these side effects may be.
Estonian: On oluline, et te teate, millised kõrvaltoimed võivad esineda.
English: If this happens contact your doctor.
Estonian: Kui see juhtub, kontakteeruge oma arstiga.
English: Please tell your doctor or pharmacist if you are using, or have recently used, any other medicines, including medicines obtained without a prescription.
Estonian: Palun rääkige oma arstile või apteekrile, kui te kasutate või olete hiljuti kasutanud muid ravimeid, sealhulgas ilma retseptita ostetud ravimeid.
English: Taking Atacand with food and drink (in particular alcohol)
Estonian: Atacandi kasutamine koos toidu ja joogiga (eriti alkoholiga)
English: • Changes in blood test results:
Estonian: • muutused vereproovis:
English: There is no experience with the use of Atacand in children (below the age of 18 years).
Estonian: Puuduvad kogemused Atacandi kasutamise kohta lastel (alla 18-aastastel).
English: If you are using certain medicines, your doctor may need to do blood tests from time to time.
Estonian: Kui te kasutate teatud ravimeid, peab teie arst aeg-ajalt teie vereproovi kontrollima.
English: This conclusion was confirmed also in another study which looked at an even higher starting dose.
Estonian: Samale järeldusele jõuti veel ühes uuringus, milles kasutati isegi suuremat algannust.
English: Most of the antihypertensive effect is attained within 4 weeks.
Estonian: Enamus antihüpertensiivsest toimest saavutatakse 4 nädala jooksul.
English: This is medicine is used for:
Estonian: Seda ravimit kasutatakse:
English: Like all medicines, Atacand can cause side effects, although not everybody gets them.
Estonian: Nagu kõik ravimid, võib ka Atacand põhjustada kõrvaltoimeid, kuigi kõigil neid ei teki.
English: Estrada Consiglieri Pedroso, 69 BQueluz de Baixo
Estonian: Estrada Consiglieri Pedroso, 69 B - Queluz de Baixo
English: The patient should be placed supine with the legs elevated.
Estonian: Patsient tuleks asetada selili, jalad kõrgemale tõstetud.
English: Swallow the tablet with a drink of water.
Estonian: Neelake tablett koos veega.
English: Stop taking Atacand and seek medical help immediately if you have any of the following allergic reactions:
Estonian: Lõpetage Atacandi võtmine ja otsige otsekohe arstiabi, kui ilmnevad järgmised allergilised reaktsioonid:
English: AIIRAs should not be initiated during pregnancy.
Estonian: AIIRA ravi ei tohiks alustada raseduse ajal.
English: {Name and address of the manufacturer} <{tel}> <{fax}> <{e-mail}>
Estonian: {Nimi and aadress} <{tel}> <{faks}> <{e-mail}>
English: Non-Perforated calendar foil (7, 14, 28, 56 and 98 tablets)
Estonian: MINIMAALSED NÕUDED, MIS PEAVAD OLEMA KIRJAS BLISTERPAKENDIL Mitteperforeeritud kalenderfoolium (7, 14, 28, 56 ja 98 tabletti)
English: Therefore Atacand should not be given to children.
Estonian: Seetõttu ei tohiks lastele Atacandi anda.
English: Finland AstraZeneca Oy Luomanportti 3
Estonian: AstraZeneca Oy Luomanportti 3
English: FI-02200 Espoo
Estonian: FI-02200 Espoo, Finland
English: 00144 Roma
Estonian: 00144 Roma, Italy
English: WHAT ATACAND IS AND WHAT IT IS USED FOR
Estonian: MIS RAVIM ON ATACAND JA MILLEKS SEDA KASUTATAKSE
English: This corresponds to a relative risk reduction of 23%.
Estonian: Selle alusel on suhteline riski langus 23%.
English: Atacand is indicated for the:
Estonian: Atacand on näidustatud:
English: 52066 Aachen
Estonian: 52066 Aachen Germany
English: This corresponds to a relative risk reduction of 15%.
Estonian: Selle alusel on suhteline riski langus 15%.
English: There was no evidence of carcinogenicity.
Estonian: Puuduvad tõendid kartsinogeensuse kohta.
English: What Atacand contains
Estonian: Mida Atacand sisaldab
English: • A reduction in your red or white blood cells.
Estonian: • punaste või valgete vereliblede taseme langus veres.
English: In particular, tell your doctor if you are using any of the following medicines:
Estonian: Kindlasti peab teie arst teadma, kui kasutate mõnda järgnevatest ravimitest:
English: • if you have a disease of the adrenal gland called Conn's syndrome (also called primary hyperaldosteronism).
Estonian: • kui teil on neerupealiste näärmete haigus, mida nimetatakse Conni sündroomiks (ehk primaarne hüperaldosteronism);
English: Almirall, S.A. Ronda General Mitre, 151 08022 Barcelona
Estonian: Almirall, S.A. Ronda General Mitre, 151 08022 Barcelona, Spain
English: These changes were considered to be caused by the pharmacological action of candesartan.
Estonian: Need muutused on tõenäoliselt põhjustatud kandesartaani farmakoloogilisest toimest.
English: Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors.
Estonian: Väga harva võib hüpotensioon olla nii tõsine, et õigustatud on intravenoossete lahuste ja/või vasopressorite manustamine.
English: Atacand may cause a reduction in number of white blood cells.
Estonian: Atacand võib põhjustada valgete vereliblede arvu vähenemist veres.
English: Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded.
Estonian: Epidemioloogilised tõendid teratogeensuse kohta AKE inhibiitorite kasutamisel raseduse esimesel trimestril ei ole lõplikud, kuid väikest riski tõusu ei saa välistada.
English: Atacand can be taken together with other medicines for heart failure, and your doctor will decide which treatment is suitable for you.
Estonian: Atacandi võib võtta koos teiste südamepuudulikkuse ravimitega ning teie arst otsustab, milline ravi teile sobib.
English: • you must tell your doctor if you think you are (or might become) pregnant.
Estonian: • te peate teavitama oma arsti, kui te arvate, et olete rase (või võite rasestuda).
English: Pharmacotherapeutic group: Angiotensin II antagonists, plain, ATC code: C09CA06
Estonian: Farmakoterapeutiline grupp: angiotensiin II antagonistid, ATC-kood: C09CA06
English: If you are going to have an operation, tell your doctor or dentist that you are taking Atacand.
Estonian: Kui te lähete operatsioonile, rääkige oma arstile või hambaarstile, et te kasutate Atacandi.
English: High blood pressure:
Estonian: Kõrge vererõhk:
English: Atacand and associated names (see Annex I) 2 mg tablets Atacand and associated names (see Annex I) 4 mg tablets Atacand and associated names (see Annex I) 8 mg tablets Atacand and associated names (see Annex I) 16 mg tablets Atacand and associated names (see Annex I) 32 mg tablets
Estonian: Atacand ja seotud nimed (vt Lisa I) 2 mg tabletid Atacand ja seotud nimed (vt Lisa I) 4 mg tabletid Atacand ja seotud nimed (vt Lisa I) 8 mg tabletid Atacand ja seotud nimed (vt Lisa I) 16 mg tabletid Atacand ja seotud nimed (vt Lisa I) 32 mg tabletid
English: Other possible side effects include:
Estonian: Teisteks kõrvaltoimeteks võivad olla:
English: • if you have low blood pressure.
Estonian: • kui teil on madal vererõhk;
English: Patients with such treatment should be monitored regularly and carefully.
Estonian: Sellist ravi saavaid patsiente tuleb regulaarselt ja hoolikalt jälgida.
English: Whilst there is no controlled epidemiological data on the risk with AIIRAs, similar risks may exist for this class of drugs.
Estonian: Kui puuduvad kontrollitud epidemioloogilised andmed riski kohta AIIRA kasutamisel, võivad samad riskid esineda ka selle ravimrühma kasutamisel.
English: • if you are more than 3 months pregnant (it is also better to avoid Atacand in early pregnancysee pregnancy section).
Estonian: • kui olete enam kui kolm kuud rase (Atacandi on parem vältida ka varajase raseduse ajal - vt lõik raseduse kohta);
English: Your doctor may occasionally do blood tests to check whether Atacand has had any effect on your blood (agranulocytosis).
Estonian: Teie arst võib aeg-ajalt kontrollida teie vereproovi, et määrata, kas Atacand on mõjutanud teie verd (agranulotsütoos).
English: 2730-055 Barcarena Portugal
Estonian: 2730-055 Barcarena
English: Takeda Global Research and Development Centre (Europe) Ltd 61 Aldwych
Estonian: Takeda Global Research and Development Centre (Europe) Ltd
English: This helps to lower your blood pressure.
Estonian: See aitab langetada vererõhku.
English: Very rare (affects less than 1 user in 10,000)
Estonian: Väga harva esinevad kõrvaltoimed (vähem kui ühel patsiendil 10000-st):
English: • Respiratory infection.
Estonian: • hingamisteede infektsioon;
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF ATACAND AND ASSOCIATED NAMES (SEE ANNEX I)
Estonian: RAVIMI ATACAND JA SARNASTE NIMETUSTE (VT I LISA) TEADUSLIKU HINDAMISE ÜLDKOKKUVÕTE
English: No data are available.
Estonian: Puuduvad andmed.
English: • if you have recently had a kidney transplant.
Estonian: • kui teil on hiljuti teostatud neerusiirdamine;
English: It also makes it easier for your heart to pump blood to all parts of your body.
Estonian: Seetõttu on südamel kergem pumbata verd kogu organismi.
English: Based on in vitro data, no interaction would be expected to occur in vivo with drugs whose metabolism is dependent upon cytochrome P450 isoenzymes CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 or CYP3A4.
Estonian: In vitro uuringute andmete põhjal ei peaks in vivo koostoimeid esinema ravimitega, mille metabolism sõltub tsütokroom P450 isoensüümidest CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 või CYP3A4.
English: Your resistance to infection may be decreased and you may notice tiredness, an infection or a fever.
Estonian: Teie vastupanu nakkustele võib olla nõrgenenud ning teil võib tekkida väsimus, mõni nakkushaigus või palavik.
English: Atacand should be taken once daily with or without food.
Estonian: Atacandi manustatakse üks kord ööpäevas, koos toiduga või ilma.
English: • Acetylsalicylic acid (if you are taking more than 3 g each day) (medicine to relieve pain and inflammation).
Estonian: • atsetüülsalitsüülhape ( kui te kasutate enam kui 3 g ööpäevas) (valu ja põletikku leevendav ravim);
English: There is currently no data on the effect of candesartan on the progression to diabetic nephropathy.
Estonian: Praegu ei ole andmeid kandesartaani toimest diabeetilise nefropaatia progresseerumisele.
English: The CHMP discussed the rational for this exclusion.
Estonian: Inimravimite komitee arutas selle piirangu põhjendatust.
English: The renal elimination of candesartan is both by glomerular filtration and active tubular secretion.
Estonian: Kandesartaani renaalne eliminatsioon toimub nii glomerulaarfiltratsiooni kui ka aktiivse tubulaarsekretsiooni teel.
English: Detailed information on this product is available on the website of : {name of MS/Agency}
Estonian: Täpne informatsioon selle ravimi kohta on kättesaadav {Liikmesriik/Amet} kodulehel
English: The apparent volume of distribution of candesartan is 0.1 l/kg.
Estonian: Kandesartaani jaotusruumala on 0,1 l/kg.
English: The CHMP thus endorsed the wording “Essential hypertension”.
Estonian: Inimravimite komitee kinnitas selle näidustuse sõnastustuses „Essentsiaalne hüpertensioon”.
English: • Do not use Atacand after the expiry date which is stated on the carton, blister pack or bottle.
Estonian: • Mitte kasutada pärast pakendile, blistriribale ja pudelile märgitud kõlblikkusaja lõppu.